Feeley Kevin 4

What Happened

• Kevin Feeley, Chief Financial Officer of GeneDx Holdings Corp. (WGS), had 754 restricted stock units (RSUs) settle into 754 shares on April 29, 2026. To cover tax withholding obligations tied to that settlement, he sold 392 of those shares in an open‑market transaction, receiving approximately $25,555 (weighted average price $65.19).

Key Details

• Transaction date: April 29, 2026. Filing date: May 1, 2026 (timely).
• RSU settlement: 754 RSUs converted to 754 shares (reported as derivative "exercise/conversion" at $0.00 per share).
• Sale: 392 shares sold (open market) for a weighted average price of $65.19; sale price range reported as $64.4739 to $65.20 per share.
• Reason for sale: Sell-to-cover for tax withholding (not a discretionary sale by the reporting person).
• Holdings after transaction: The filing reports Feeley beneficially owned 34,942 shares of Class A common stock, plus RSUs representing rights to up to 92,419 additional shares and options to purchase up to 25,906 shares (vesting per the grant terms).
• Vesting notes: The RSU award vests per the schedule in the footnote (25% vested on 4/29/2023 and 4/29/2024, with remaining quarterly tranches through 4/29/2026).

Context

• This was an RSU settlement with a partial sell-to-cover for taxes — a routine administrative transaction common after vesting, not an independent market-timing sale. The "M" derivative entries reflect conversion/settlement of the RSUs; the subsequent open-market sale was to satisfy withholding.